Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sanjay Sikka

Gastroenterology Oklahoma City, OK Medical Doctor

NPI 1528295698 CMS profile 115354

3435 Nw 56Th St Ste 101, Oklahoma City, OK 73112

Open in the dashboard

General payments

$30,825

211 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sanjay Sikka of Oklahoma City, OK is reported in the CMS Open Payments database as having received $30,825 across 211 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,996 29
2024 General $190 6
2023 General $3,632 38
2022 General $20,330 76
2021 General $2,008 25
2020 General $1,221 24
2019 General $1,448 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sanjay Sikka
  • Gastroenterology median
  • Middle half of Gastroenterology
  • National median

In program year 2025, general payments to Sanjay Sikka were reported at $1,996. Among 13,050 Gastroenterology profiles paid that year, the median was $639 and the middle half received between $167 and $1,700.

Show as a table
Year Sanjay Sikka Gastroenterology median Middle half National median
2019 $1,448 $417 $126–$1,100 $163
2020 $1,221 $224 $74–$624 $114
2021 $2,008 $352 $106–$1,054 $132
2022 $20,330 $448 $129–$1,270 $149
2023 $3,632 $533 $150–$1,390 $160
2024 $190 $605 $160–$1,606 $164
2025 $1,996 $639 $167–$1,700 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $22,276 105 payments
  2. Olympus Corporation of the Americas $5,255 38 payments
  3. Cook Medical LLC $1,215 27 payments
  4. Olympus America Inc. $676 14 payments
  5. AbbVie, Inc. $351 5 payments
  6. Lumendi LLC $223 2 payments
  7. Ambu Inc. $159 1 payment
  8. Relypsa, Inc. $120 1 payment
  9. Steris Corporation $107 1 payment
  10. E.R. Squibb & Sons, L.L.C. $101 1 payment
  11. Other $342 16 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $12,717 50 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $10,200 7 payments
  3. Food and Beverage $7,855 153 payments
  4. Gift $53 1 payment
Products named General payments · program years 2019–2025
  1. EXALT Model D Exalt_Endo $7,622 14 payments
  2. EXALT Model D EXALT Model D_ENDO $6,422 12 payments
  3. Single Use Electrosurgical Hemostatic Forceps $3,309 27 payments
  4. DISPOSABLE DISTAL ATTACHMENT $2,525 13 payments
  5. ORISE $2,458 22 payments
  6. Single Use Electrosurgical Knife KD-655 $2,287 20 payments
  7. Olympus EMR & ESD Devices $956 12 payments
  8. Olympus $881 4 payments
  9. General - Therapies $860 4 payments
  10. General Therapies $806 2 payments
  11. Other $7,714 128 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

90

Median for Gastroenterology: 569

Drug cost

$2,312

Median for Gastroenterology: $104,976

Branded share of claims

40%

Median for Gastroenterology: 31.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ursodiol Generic 13 $1,381
Omeprazole Generic 16 $377
Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl Brand 23 $371
Lidocaine Hcl Viscous Lidocaine Hcl Brand 13 $97
Ciprofloxacin Hcl Generic 25 $86

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,294 Part D prescribers listed as Gastroenterology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 54 billing codes

Paid by Medicare

$97,651

Medicare's payments for the services billed

Medicare patients

257

Average age 74

Services billed

669

120 women, 137 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 58%
Ischemic heart disease 49%
Diabetes 43%
Chronic kidney disease 39%
Atrial fibrillation 29%
Heart failure 26%
COPD 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
RINVOQ
  • AbbVie, Inc. $8
$8 — —
SKYRIZI
  • AbbVie, Inc. $8
$8 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

211 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in Oklahoma

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record